The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 08, 2011
Filed:
Apr. 20, 2007
Robert O Hughes, Eureka, MO (US);
Andrew Simon Bell, Sandwich, GB;
David Graham Brown, Sandwich, GB;
Dafydd Owen, Sandwich, GB;
Michael John Palmer, Sandwich, GB;
Christopher Phillips, Sandwich, GB;
David L. Brown, Chesterfield, MO (US);
Yvette M. Fobian, Wildwood, MO (US);
John N. Freskos, Clayton, MO (US);
Steven E. Heasley, St. Charles, MO (US);
E. Jon Jacobsen, Chesterfield, MO (US);
Todd Maddux, Foristell, MO (US);
Brent Mischke, Defiance, MO (US);
John M. Molyneaux, St. Louis, MO (US);
Joseph B. Moon, University City, MO (US);
D. Joseph Rogier, Jr., Chesterfield, MO (US);
Michael B. Tollefson, Dardenne Prairie, MO (US);
John K. Walker, Weldon Spring, MO (US);
Robert O Hughes, Eureka, MO (US);
Andrew Simon Bell, Sandwich, GB;
David Graham Brown, Sandwich, GB;
Dafydd Owen, Sandwich, GB;
Michael John Palmer, Sandwich, GB;
Christopher Phillips, Sandwich, GB;
David L. Brown, Chesterfield, MO (US);
Yvette M. Fobian, Wildwood, MO (US);
John N. Freskos, Clayton, MO (US);
Steven E. Heasley, St. Charles, MO (US);
E. Jon Jacobsen, Chesterfield, MO (US);
Todd Maddux, Foristell, MO (US);
Brent Mischke, Defiance, MO (US);
John M. Molyneaux, St. Louis, MO (US);
Joseph B. Moon, University City, MO (US);
D. Joseph Rogier, Jr., Chesterfield, MO (US);
Michael B. Tollefson, Dardenne Prairie, MO (US);
John K. Walker, Weldon Spring, MO (US);
Pharmacia & Upjohn Company LLC, Kalamazoo, MI (US);
Abstract
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R, R, Rand Rare as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, synthetic methods, and intermediates are also disclosed.